PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
March 19, 2026Frontiers in Oncology0 citationsOpen Access

Transanal sphincter-sparing local excision for primary anorectal malignant melanoma: a case report

ZWZhiting WangJHJianwen HuYXYingfeng Xu

Key Points

Key points are not available for this paper at this time.

Abstract

Background: Anorectal malignant melanoma (ARMM) is a rare and highly aggressive malignancy with a poor prognosis. Surgical resection remains the primary treatment strategy, with local excision (LE) and extended resection (ER) being the most commonly performed approaches. However, the optimal surgical management remains controversial, particularly regarding oncologic control and sphincter preservation. Case presentation: We report a 61-year-old man who presented with painless hematochezia for one month. Imaging revealed a 4 × 4 cm mass near the dentate line, and colonoscopic biopsy confirmed malignant melanoma. After multidisciplinary evaluation, transanal sphincter-preserving local excision was performed under combined spinal-epidural anesthesia. The tumor was resected with preservation of anal function, and the postoperative course was uneventful without fecal incontinence. However, the patient died 14 months after surgery. Conclusion: This case illustrates that transanal sphincter-sparing local excision may be a feasible surgical option for carefully selected patients with localized primary anorectal malignant melanoma without sphincter involvement or distant metastasis. Nevertheless, longer follow-up and further studies are required to evaluate long-term oncologic outcomes.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Wang et al. (2026) studied this question.

synapsesocial.com/papers/6a224615e8ef4064f24ed9f1https://doi.org/10.3389/fonc.2026.1730918
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1KIT, NRAS, BRAF and FMNL2 mutations in oral mucosal melanoma and a systematic review of the literature2018 · 21 citations
  2. 2Anorectal Melanoma2009 · 78 citations
  3. 3Immunohistochemical characteristics of melanoma2008 · 596 citations
  4. 4Anorectal Melanoma2011 · 62 citations
  5. 5Efficacy and Safety of Nivolumab Alone or in Combination With Ipilimumab in Patients With Mucosal Melanoma: A Pooled Analysis2017 · 657 citations